Peptide merchant accounts

Mainstream processors have left this category. We underwrite it on documentation, register the account correctly with the card networks, and keep your subscribers on a vault that is yours if a processor ever changes its mind.

Why banks decline peptides

• The card networks classify peptides as an integrity-risk category, which means extra registration, extra fees and site monitoring for the acquirer. Many acquirers refuse the category rather than do the work.
• The product sits in a regulatory grey area, and a few bad actors with health claims and no lab documentation have made banks suspicious of everyone.
• Chargeback ratios in the category ran high in 2023 and 2024, so processors that once tolerated it now decline on sight.
• Stripe, PayPal and Square have exited research peptides, so sellers arrive with no processing history or with a termination on file.

What we need from you

Underwriting reads the site before it reads the application. Have these ready and a complete application goes live in 24 hours.

• Research-use policies and disclaimers on the site and on every product page
• Product copy free of health, dosing or outcome language; the products are described as research compounds and nothing more
• A certificate of analysis or supplier verification for what you sell
• A billing descriptor that matches your brand, so customers recognise the charge
• Fulfillment proof: inventory, a 3PL agreement or a shipping SLA
• Formation documents and an EIN or your country's equivalent
• Owner identification (a passport is fine; no SSN needed for non-US owners)
• A voided check or bank letter for the settlement account
• Processing and chargeback history from your current processor, if you have one
• Published refund, shipping and privacy policies, and terms that match how you actually bill

What you get

• An account registered under the card networks' integrity-risk program from day one, coded correctly, so you are not reclassified or fined later.
• More than one merchant account behind your vault where the volume justifies it, so one processor exiting the category is a routing change for you, not an outage.
• Retries on soft declines within the network rules, and routing tuned to your card mix.
• A vault under your name: card tokens, customer profiles and subscription schedules that move with you.

What we cannot support

Saying it here saves you an application.

• Sites that carry health, dosing or outcome claims, in copy, images or reviews
• Products the card networks prohibit
• Sellers who cannot document what they ship

Questions peptides merchants ask

Is research peptide processing still possible in 2026?

Yes, with the checklist above. The mainstream processors left the category; specialists underwrite it on documentation and register it correctly. Prepared applications move on a normal timeline.

Do I need LegitScript certification?

No. A research-use storefront is underwritten on documentation: research-use policies, clean product copy and a certificate of analysis for what you sell. Certification is a requirement of licensed healthcare and compounding models, which is a different lane from research supply.

Will there be a reserve?

Often, yes, and it is stated in your offer before you sign: typically a rolling reserve that releases on a schedule. We do not hold more than the vertical requires.

What happens to my subscribers if a processor drops the category?

Nothing they notice. Their tokens live in your vault, not at the processor, so we route to another account and the rebills continue.